Business Wire

THALES

Share
Thales Announces New Solutions to Help Organisations Discover, Protect and Control Sensitive Data in Multicloud Environments

Thales today announced new data protection solutions for Google Cloud, Microsoft Azure, and Amazon Web Services, solidifying its role as a trusted third party for multicloud data security.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210518005282/en/

With each cloud provider having unique data protection mechanisms and key management offerings, multicloud data protection presents a complex security challenge for organisations. Thales’ latest cloud data security solutions allow customers to maintain control of and manage their encryption keys, as well as manage access and authentication across hybrid and multicloud environments.

“These capabilities are critical to cloud migration and security, especially with such accelerated growth in this area,” said Sunil Potti, Vice President and General Manager of Google Cloud Security . “True to our mission, we have forged this collaboration with Thales to further protect our customer’s most sensitive information. We are empowering customers to leverage the full potential of Google Cloud technology for sensitive workloads, by utilising the Customer-Managed Encryption Key-integrated GCP services, CipherTrust Cloud Key Manager and SafeNet Trusted Access for access management and authentication from Thales. This will enable enterprises to deal with a fluid and dynamic business environment where protecting sensitive data in the cloud is of extreme importance.”

Simplifying Multicloud Security

As customers look to reap the rewards from multicloud environments, Thales is making it easier to ensure protection against reputational risk and financial penalties arising from a cloud data breach. As such, customers will benefit from enhanced capabilities to Discover, Protect and Control sensitive data across multicloud environments, including the ability to:

Discover Sensitive Data in the Cloud and On-Premises

Thales Data Discovery and Classification automates the discovery, classification and protection of data in the cloud and on-premises using automation policies that identify sensitive data and protect the data with encryption or tokenisation. These capabilities have now been extended to the discovery and classification of data in Amazon Web Services S3 buckets and Azure Blob storage.

Protect Sensitive Data and Workloads in the Cloud

To address both the complexity of where data is stored and to help ensure data sovereignty in a multicloud environment, effective encryption and tokenisation is needed. Specific new data protection capabilities for cloud platforms include:

  • CipherTrust Transparent Encryption for advanced encryption and access controls, protects data in Amazon Web Services Simple Storage Service (S3)
  • Encryption of Kubernetes secrets and Google Anthos Service Mesh signing keys

Control Access to Applications and Sensitive Data in the Cloud

The accelerated adoption of encryption has led to the need to manage a far larger number of encryption keys across both traditional data stores and multicloud environments. Thales has enabled new capabilities that allow organisations to control access to data and ownership of their encryption keys, including:

  • Thales is also offering CipherTrust Cloud Key Manager support for Google Cloud’s External Key Manager (EKM), building on the existing CipherTrust Key Broker for Google Cloud EKM which is part of the Thales Data Protection on Demand cloud-based platform.

Secure and Protect access at the Login Point

Compromised identities pose one of the greatest risks for data breaches:

  • SafeNet Trusted Access integrates out of the box with Google Workspace, Azure and AWS, enforcing the appropriate access controls and authentication for privileged and regular users.
  • SafeNet Trusted Access is offering new abilities to provide authentication and authorisation for APIs and for applications not using industry-standard protocols such as SAML and OIDC.

“The proliferation of multicloud computing has created new organizational challenges in managing data across many different cloud environments. Whilst organisations have benefited from scalability and speed to market thanks to the power of cloud, the ever expanding IT cloud landscape has added greater complexity to data management and security,” said Sébastien Cano, Senior Vice President, Cloud Protection and Licensing activities at Thales . “In a post pandemic, highly regulated world, it is even more important for organisations to understand what data they have, where it sits, who can access it and the risks associated with managing it. Only once an organization understands all of these data lifecycle aspects, can they ensure that it is secured and managed correctly.”

Additional Resources

Thales and Google Cloud have forged a strong collaboration to help enterprises migrate sensitive data between public cloud, hybrid and private IT infrastructures. Watch this video with Sunil Potti, VP and GM at Google Cloud Security to learn more.

About Thales

Thales (Euronext Paris: HO) is a global leader in advanced technologies, investing in digital and “deep tech” innovations – connectivity, big data, artificial intelligence, cybersecurity and quantum computing – to build a confident future crucial for the development of our societies. The Group provides its customers – businesses, organisations and governments – in the defense, aeronautics, space, transport, and digital identity and security domains with solutions, services and products that help them fulfil their critical role, consideration for the individual being the driving force behind all decisions.

Thales has 81,000 employees in 68 countries. In 2020 the Group generated sales of €17 billion.

Thales Group
Security

Link:

ClickThru

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

DATROWAY® Type II Variation Application Validated in the EU as First-Line Treatment for Patients with Metastatic Triple Negative Breast Cancer Who are Not Candidates for Immunotherapy18.12.2025 08:30:00 CET | Press release

Based on TROPION-Breast02 phase 3 trial results where Daiichi Sankyo and AstraZeneca’s DATROWAY is the first and only medicine to significantly improve overall survival versus chemotherapy in this patient population If approved, DATROWAY could become the standard of care in this setting The European Medicines Agency (EMA) has validated the Type II Variation marketing authorization application for DATROWAY® (datopotamab deruxtecan) as monotherapy for the first-line treatment of adult patients with unresectable or metastatic triple negative breast cancer (TNBC) who are not candidates for PD-1/PD-L1 inhibitor therapy. DATROWAY is a specifically engineered TROP2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/Nasdaq: AZN). The validation confirms the completion of the application and commences the scientific review process by the EMA’s Committee for Medicinal Produc

Celltrion receives positive CHMP Opinion for SteQeyma™ (ustekinumab biosimilar) autoinjector18.12.2025 03:41:00 CET | Press release

SteQeyma™45mg and 90mg solution for injection via autoinjector (pre-filled pen) receives positive CHMP opinion, which will facilitate subcutaneous administration in patients with plaque psoriasis, psoriatic arthritis (PsA) and Crohn’s disease (CD)1The new autoinjector option increases convenience, enhances individual patient experience and expands administration options Celltrion, Inc. today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion of autoinjector of SteQeyma™, a biosimilar to Stelara® (ustekinumab), for the treatment of plaque psoriasis, psoriatic arthritis (PsA) and Crohn’s disease (CD). The positive CHMP opinion is for SteQeyma autoinjector in 45mg/0.5mL and 90mg/1mL, expanding the currently approved SteQeyma™ presentation, which includes 45mg/0.5mL, 90mg/1mL in a pre-filled syringe and 45mg/0.5mL in a vial for subcutaneous injection, as well as 130mg/26mL concentrate for solution f

Megaport Expands into India, Accelerating Global Growth with Extreme IX Acquisition18.12.2025 02:15:00 CET | Press release

Through the Extreme Exchange (IX) acquisition, Megaport gains seven Internet Exchanges and access to 40+ data centres across India’s fastest-growing digital hubs. Megaport Limited (ASX: MP1) (“Megaport”), the world’s leading Network as a Service (NaaS) provider, today announced the acquisition of Extreme IX,India’s leading Internet Exchange operator, from Extreme Labs, a Bulgaria-headquartered software and network engineering company that incubated the Extreme IX platform. The acquisition expands Megaport’s global platform into one of the world’s fastest-growing digital infrastructure markets and supports the Company’s strategy to deliver scalable, high-performance connectivity services across APAC. The acquisition establishes Megaport’s presence across seven Internet Exchanges in major Indian metros: Delhi, Kolkata, Hyderabad, Chennai, Bengaluru, Mumbai, and Pune, connecting 40+ data centres and more than 400 customers. It also accelerates Megaport’s planned market entry by nearly thr

IonQ and QuantumBasel Expand Long-Term Partnership in Next-Generation Quantum Systems17.12.2025 22:10:00 CET | Press release

Extension solidifies QuantumBasel as IonQ’s Innovation Center in Europe; adds IonQ Tempo and next-generation system to advance quantum commercialization IonQ (NYSE: IONQ), the world’s leading quantum company, today announced an expanded agreement with QuantumBasel, the quantum initiative of uptownBasel, Switzerland’s innovation campus. The extended contract grants QuantumBasel ownership of its existing IonQ Forte Enterprise system and secures ownership of a next-generation Tempo system. This new agreement brings the total deal value of the QuantumBasel and IonQ partnership to over $60 million and extends IonQ’s on-site presence in Switzerland four more years, continuing through 2029. QuantumBasel is IonQ’s official Innovation Center in Europe, serving as a hub for European industry, academia, and research institutions to explore practical quantum computing applications and access IonQ’s latest enterprise-grade systems. “Our extended partnership with QuantumBasel represents a cornerston

Suzano Starts Up New Production Line, Boosting Its Fluff Pulp Capacity by 400%17.12.2025 21:50:00 CET | Press release

A R$490 million investment expands the supply of raw material used in the production of absorbent items Suzano, the world’s largest pulp producer, has commenced operations this week at its new fluff pulp production line located in its Limeira unit in Brazil’s São Paulo state. This R$490 million investment increases Suzano’s total fluff pulp production capacity by more than 400%, from 100,000 to 440,000 tonnes per year. The project involved converting the existing pulp line at the Limeira unit into a flexible machine, capable of producing both Eucafluff® and market pulp. Eucafluff® is used in the production of absorbent and personal hygiene products, such as baby and adult diapers, sanitary pads and pet pads. Then market pulp is supplied for making products including toilet paper, printing and writing papers, and paper packaging. Launched in 2015, Eucafluff® is the world’s first fluff pulp made from eucalyptus, delivering unique advantages like enhanced softness and flexibility, which t

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye